Health
Scientists lay out a novel rationale for COVID-19 drug design – News-Medical.Net
American and Polish scientists, reporting Oct. 16 in the journal Science Advances, laid out a novel rationale for COVID-19 drug design – blocking a molecular “s…
Reviewed by Emily Henderson, B.Sc.Oct 19 2020
American and Polish scientists, reporting Oct. 16 in the journal Science Advances, laid out a novel rationale for COVID-19 drug design – blocking a molecular “scissor” that the virus uses for virus production and to disable human proteins crucial to the immune response.
The researchers are from The University of Texas Health Science Center at San Antonio (UT Health San Antonio) and the Wroclaw University of Science and Technology. Information glean…
-
Business19 hours ago1 ASX dividend stock down 43% I’d buy right now
-
Noosa News19 hours agoBanana farmers still salvaging fruit four weeks after ex-Tropical Cyclone Alfred
-
Business23 hours agoBattle of the ASX ETFs: Why has VGS outperformed VTS this year?
-
Business22 hours ago5 things to watch on the ASX 200 on Monday 7 April 2025